Further investigations in other (neuro)endocrine tumour entities with a high prevalence of GPR68, such as pheochromocytomas, paragangliomas, and medullary thyroid carcinomas, but also with cervical adenocarcinomas and endometrial cancer will be of interest in this respect. The gene discussed is GPR68; the disease is paraganglioma.